BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31318857)

  • 1. From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
    Colebunders R; Siewe Fodjo JN; Hopkins A; Hotterbeekx A; Lakwo TL; Kalinga A; Logora MY; Basáñez MG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007407. PubMed ID: 31318857
    [No Abstract]   [Full Text] [Related]  

  • 2. Scientists celebrate successes, new tools in fight against human parasitic worms.
    Kuehn BM
    JAMA; 2013 Jul; 310(1):19-20. PubMed ID: 23821071
    [No Abstract]   [Full Text] [Related]  

  • 3. River blindness: a success story under threat?
    Basáñez MG; Pion SD; Churcher TS; Breitling LP; Little MP; Boussinesq M
    PLoS Med; 2006 Sep; 3(9):e371. PubMed ID: 17002504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of onchocerciasis control in Africa.
    Hodgkin C; Molyneux DH; Abiose A; Philippon B; Reich MR; Remme JH; Thylefors B; Traore M; Grepin K
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e74. PubMed ID: 17989787
    [No Abstract]   [Full Text] [Related]  

  • 5. Head nodding syndrome and river blindness: a parasitologic perspective.
    Kaiser C; Pion S; Boussinesq M
    Epilepsia; 2009 Oct; 50(10):2325-6. PubMed ID: 19785668
    [No Abstract]   [Full Text] [Related]  

  • 6. African Programme for Onchocerciasis Control: progress report, 2013-2014.
    Wkly Epidemiol Rec; 2014 Dec; 89(49):551-60. PubMed ID: 25485343
    [No Abstract]   [Full Text] [Related]  

  • 7. A new key-player for onchocerciasis elimination.
    Jesudason T
    Lancet Infect Dis; 2023 Apr; 23(4):413. PubMed ID: 36965498
    [No Abstract]   [Full Text] [Related]  

  • 8. After 70 years of fighting an age-old scourge, onchocerciasis in Uganda, the end is in sight.
    Katabarwa MN; Lakwo T; Habomugisha P; Unnasch TR; Garms R; Hudson-Davis L; Byamukama E; Khainza A; Ngorok J; Tukahebwa E; Richards FO
    Int Health; 2018 Mar; 10(suppl_1):i79-i88. PubMed ID: 29471335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the NGDO Coordination Group for the Elimination of Onchocerciasis.
    Elhassan E; Zhang Y; Bush S; Molyneux D; Kollmann MKH; Sodahlon Y; Richards F
    Int Health; 2018 Mar; 10(suppl_1):i97-i101. PubMed ID: 29471339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward elimination of onchocerciasis in the Americas.
    Sauerbrey M; Rakers LJ; Richards FO
    Int Health; 2018 Mar; 10(suppl_1):i71-i78. PubMed ID: 29471334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.
    Kim YE; Remme JH; Steinmann P; Stolk WA; Roungou JB; Tediosi F
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003664. PubMed ID: 25860569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
    Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
    Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. River blindness elimination in Columbia.
    Burki T
    Lancet Infect Dis; 2013 Nov; 13(11):922-3. PubMed ID: 24319775
    [No Abstract]   [Full Text] [Related]  

  • 14. River Blindness: Mathematical Models for Control and Elimination.
    Basáñez MG; Walker M; Turner HC; Coffeng LE; de Vlas SJ; Stolk WA
    Adv Parasitol; 2016; 94():247-341. PubMed ID: 27756456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. River blindness eliminated in Colombia.
    West S; Munoz B; Sommer A
    Ophthalmic Epidemiol; 2013 Oct; 20(5):258-9. PubMed ID: 23968291
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful elimination of onchocerciasis (river blindness) vectors from isolated foci in two African countries.
    Brattig NW
    Acta Trop; 2009 Sep; 111(3):201-2. PubMed ID: 19619685
    [No Abstract]   [Full Text] [Related]  

  • 17. African Programme for Onchocerciasis Control: progress report, 2014–2015.
    Wkly Epidemiol Rec; 2015 Dec; 90(49):661-74. PubMed ID: 26638222
    [No Abstract]   [Full Text] [Related]  

  • 18. Transitioning from river blindness control to elimination: steps toward stopping treatment.
    Cantey PT; Roy SL; Boakye D; Mwingira U; Ottesen EA; Hopkins AD; Sodahlon YK
    Int Health; 2018 Mar; 10(suppl_1):i7-i13. PubMed ID: 29471338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness.
    Bhattacharyya S; Vinkeles Melchers NVS; Siewe Fodjo JN; Vutha A; Coffeng LE; Logora MY; Colebunders R; Stolk WA
    PLoS Negl Trop Dis; 2023 May; 17(5):e0011320. PubMed ID: 37235598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.
    Turner HC; Walker M; Churcher TS; Basáñez MG
    Parasit Vectors; 2014 May; 7():241. PubMed ID: 24886747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.